$25.23
0.255[1.02%]
At close: Apr 24
$25.23
0[0.00%]
After Hours: 7:32PM EDT
vTv Therapeutics
(NASDAQ:VTVT)Latest News for vTv Therapeutics Stock (NASDAQ:VTVT)
vTv Therapeutics Stock (NASDAQ: VTVT)
Categories: All
Wednesday, March 13, 2024
Tuesday, March 05, 2024
Monday, March 04, 2024
Wednesday, February 28, 2024
- S&P 500 Edges Lower; ADT Posts Upbeat EarningsAvi Kapoor - Feb 28, 2024, 2:30PM
- Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionAvi Kapoor - Feb 28, 2024, 2:02PM
- Why Is Diabetes Focused vTv Therapeutics Stock Trading Higher Today?Vandana Singh - Feb 28, 2024, 1:53PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Feb 28, 2024, 12:31PM
- Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M BarrelsAvi Kapoor - Feb 28, 2024, 12:25PM
- vTv Therapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 117.4%Benzinga Newsdesk - Feb 28, 2024, 11:33AM
- vTv Therapeutics Shares Resume TradingBenzinga Newsdesk - Feb 28, 2024, 11:32AM
- vTv Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 143.3%Benzinga Newsdesk - Feb 28, 2024, 11:27AM
- vTv Therapeutics Shares Resume TradeBenzinga Newsdesk - Feb 28, 2024, 11:27AM
- vTv Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 105.7%Benzinga Newsdesk - Feb 28, 2024, 11:17AM
- vTv Therapeutics Entered Into A Sales Agreement With Cowen And Company; Pursuant To Agreement Co May Offer And Sell Shares Of Class A Common Stock Having Aggregate Offering Price Of Up To $50.0MBenzinga Newsdesk - Feb 28, 2024, 9:32AM
- vTv Therapeutics shares are trading higher after the company announced a $51 million private placement from healthcare-focused institutional investors and the JDRF T1D Fund.Benzinga Newsdesk - Feb 28, 2024, 9:30AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Feb 28, 2024, 8:06AM
- vTv Therapeutics Announces $51M Private Placement From Healthcare-focused Institutional Investors Including Samsara BioCapital And The JDRF T1D FundBenzinga Newsdesk - Feb 28, 2024, 8:03AM
Wednesday, January 24, 2024
Tuesday, January 23, 2024
Monday, January 22, 2024
Tuesday, December 19, 2023
Tuesday, December 12, 2023
Friday, December 01, 2023
Wednesday, November 29, 2023
Friday, November 24, 2023
Tuesday, November 21, 2023
- Gold Rises 1%; Hibbett Shares Spike HigherLisa Levin - Nov 21, 2023, 2:34PM
- Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Nov 21, 2023, 1:28PM
- Nasdaq Falls Over 100 Points; Burlington Shares Jump After Q3 ResultsLisa Levin - Nov 21, 2023, 12:04PM
- vTv Therapeutics shares are trading lower after the company announced a 1-for-40 reverse stock split.Benzinga Newsdesk - Nov 21, 2023, 11:32AM
- On November 20, vTv Therapeutics Announced A 1-For-40 Reverse Stock SplitBenzinga Newsdesk - Nov 21, 2023, 11:31AM
- VTv Therapeutics Shares Resume TradeBenzinga Newsdesk - Nov 21, 2023, 9:00AM
Thursday, November 09, 2023
Wednesday, November 01, 2023
Friday, August 11, 2023
Thursday, August 10, 2023
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Aug 10, 2023, 9:06AM
- Cantex Pharmaceuticals Announces Article Published In npj Breast Cancer Highlighting Potential Role Of RAGE Inhibition To Prevent Metastasis In Triple-Negative Breast CancerBenzinga Newsdesk - Aug 10, 2023, 8:34AM
Thursday, July 27, 2023
Thursday, July 20, 2023
Thursday, June 22, 2023
Thursday, June 01, 2023
- 12 Health Care Stocks Moving In Thursday's After-Market SessionBenzinga Insights - Jun 1, 2023, 5:39PM
- Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights To Intellectual Property From Georgetown University For Azeliragon As A Potential Treatment Of Cancer-related Cognitive Decline; NOTE: Azeliragon Was Discovered By vTv And Licensed To Cantex PharmaHappy Mohamed - Jun 1, 2023, 10:49AM